Position in ZTS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$10,787,844
-$11,533,630 QoQ
Shares Held
91,260
-48.6% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026STOREBRAND ASSET MANAGEMENT AS holds $76,715,400 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
93,743 | $55,587,724 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
91,260 | $10,787,844 | |
| 3 | VTRS |
Viatris Inc
|
726,652 | $9,817,068 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
17,885 | $427,988 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
581 | $76,540 | |
| 6 | HCM |
HUTCHMED (China) Ltd
|
1,219 | $18,236 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,787,844 | 91,260 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $22,321,474 | 177,408 | Shares | Sole | 2026-05-20 | |
| 2025-09-30 | $33,854,058 | 231,370 | Shares | Sole | 2026-06-03 | |
| 2025-06-30 | $35,942,888 | 230,477 | Shares | Sole | 2026-06-03 | |
| 2025-03-31 | $38,972,655 | 236,700 | Shares | Sole | 2026-06-03 | |
| 2024-12-31 | $41,104,469 | 252,283 | Shares | Sole | 2026-06-17 | |
| 2024-09-30 | $47,867,709 | 244,998 | Shares | Sole | 2026-06-17 | |
| 2024-06-30 | $40,579,588 | 234,077 | Shares | Sole | 2026-06-17 | |
| 2024-03-31 | $44,828,636 | 264,929 | Shares | Sole | 2026-06-17 | |
| 2023-12-31 | $53,917,733 | 273,181 | Shares | Sole | 2026-06-18 | |
| 2023-09-30 | $42,708,610 | 245,480 | Shares | Sole | 2026-06-18 | |
| 2023-06-30 | $41,566,672 | 241,372 | Shares | Sole | 2026-06-18 | |
| 2023-03-31 | $43,187,684 | 259,479 | Shares | Sole | 2026-06-18 | |
| 2022-12-31 | $42,110,116 | 287,343 | Shares | Sole | 2026-06-18 | |
| 2022-09-30 | $49,263,569 | 332,211 | Shares | Sole | 2026-06-18 | |
| 2022-06-30 | $57,011,959 | 331,677 | Shares | Sole | 2026-06-18 | |
| 2022-03-31 | $62,104,572 | 329,310 | Shares | Sole | 2026-06-18 | |
| 2021-12-31 | $84,609,837 | 346,719 | Shares | Sole | 2026-06-18 | |
| 2021-09-30 | $65,442,264 | 337,088 | Shares | Sole | 2026-06-18 | |
| 2021-06-30 | $62,370,405 | 334,677 | Shares | Sole | 2026-06-18 | |
| 2021-03-31 | $52,714,225 | 334,736 | Shares | Sole | 2026-06-18 | |
| 2020-12-31 | $50,800,887 | 306,954 | Shares | Sole | 2026-06-18 | |
| 2020-09-30 | $49,574,949 | 299,782 | Shares | Sole | 2026-06-18 | |
| 2020-06-30 | $42,979,444 | 313,627 | Shares | Sole | 2026-06-18 | |
| 2020-03-31 | $37,659,505 | 319,989 | Shares | Sole | 2026-06-18 | |
| No filing history on record for this holder in this stock. | ||||||